Publications

You can use the filters to show only results that match your interests

Filter publications
398 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients

  2. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  3. Implementing ‘safety features’ under the Falsified Medicines Directive

    • MHRA
    • Open consultation
  4. Annual review of good clinical practice referrals

    • MHRA
    • Official Statistics
  5. Marketing authorisations granted in June 2018

  6. Parallel import licenses granted in June 2018

  7. Common issues identified during clinical trial applications

    • MHRA
    • Guidance
  8. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  9. Register of brokers authorised to deal in human medicines

  10. Medicines: new manufacturing and wholesale dealer licences

  11. Human and veterinary medicines: register of licensed wholesale distribution sites

  12. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  13. Human and veterinary medicines: register of licensed manufacturing sites

  14. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  15. MHRA: business impact target

    • MHRA
    • Research and analysis
  16. Advertising investigations: May 2018

  17. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  18. Medical devices: software applications (apps)

  19. E-learning modules: medicines

    • MHRA
    • Guidance
  20. Medicines: notes for applicants and holders of a wholesale dealer licence or broker registration

  21. MHRA Privacy Notice

    • MHRA
    • Transparency data
  22. Marketing authorisations granted in May 2018

  23. Parallel import licenses granted in May 2018

  24. Review Panel Annual Report 2017

    • MHRA
    • Corporate report
  25. Annual reports of the ABRHP and the HMAC

    • MHRA
    • Corporate report
  26. Early access to medicines scheme (EAMS) scientific opinion: Volanesorsen as a treatment of adult patients with familial chylomicronaemia syndrome

  27. Early access to medicines scheme (EAMS) scientific opinion: Nivolumab to treat advanced or recurrent gastric or gastroesophageal junction cancer after two or more systemic therapies

  28. Government response to report on Brexit and medicines, medical devices and substances of human origin

    • DHSC, IPO, MHRA, OLS and DExEU
    • Policy paper
  29. Human Medicines Regulations 2012 Advisory Bodies annual report 2017

    • MHRA
    • Corporate report
  30. Medicines and Healthcare products Regulatory Agency Business Plan 2018 to 19

    • MHRA
    • Corporate report
  31. Marketing authorisations granted in April 2018

  32. Parallel import licenses granted in April 2018

  33. Good clinical practice inspection metrics

  34. Good clinical practice inspection metrics

  35. MHRA: policy for handling conflicts of interest

    • MHRA
    • Corporate report
  36. Advertising investigations: March 2018

  37. Advertising investigations: April 2018

  38. MHRA Corporate Plan 2018 to 2023

    • MHRA
    • Corporate report
  39. Advertising investigations: February 2018

  40. Marketing authorisations granted in March 2018